Long-term prognostic significance of response in multiple myeloma after stem cell transplantation
Published 2011 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Long-term prognostic significance of response in multiple myeloma after stem cell transplantation
Authors
Keywords
-
Journal
BLOOD
Volume 118, Issue 3, Pages 529-534
Publisher
American Society of Hematology
Online
2011-04-12
DOI
10.1182/blood-2011-01-332320
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Complete response correlates with long-term progression-free and overall survival in elderly myeloma treated with novel agents: analysis of 1175 patients
- (2011) F. Gay et al. BLOOD
- Comparison of Immunofixation, Serum Free Light Chain, and Immunophenotyping for Response Evaluation and Prognostication in Multiple Myeloma
- (2011) Bruno Paiva et al. JOURNAL OF CLINICAL ONCOLOGY
- Achievement of VGPR to induction therapy is an important prognostic factor for longer PFS in the IFM 2005-01 trial
- (2010) P. Moreau et al. BLOOD
- Attainment of at least a very good partial response after induction treatment is an important surrogate of longer survival for multiple myeloma
- (2010) D Tan et al. BONE MARROW TRANSPLANTATION
- Importance of Achieving a Complete Response in Multiple Myeloma, and the Impact of Novel Agents
- (2010) Asher A. Chanan-Khan et al. JOURNAL OF CLINICAL ONCOLOGY
- Survival and Years of Life Lost in Different Age Cohorts of Patients With Multiple Myeloma
- (2010) Heinz Ludwig et al. JOURNAL OF CLINICAL ONCOLOGY
- Bortezomib As Induction Before Autologous Transplantation, Followed by Lenalidomide As Consolidation-Maintenance in Untreated Multiple Myeloma Patients
- (2010) Antonio Palumbo et al. JOURNAL OF CLINICAL ONCOLOGY
- The role of complete response in multiple myeloma
- (2009) J.-L. Harousseau et al. BLOOD
- CR represents an early index of potential long survival in multiple myeloma
- (2009) M Wang et al. BONE MARROW TRANSPLANTATION
- Achievement of at Least Very Good Partial Response Is a Simple and Robust Prognostic Factor in Patients With Multiple Myeloma Treated With High-Dose Therapy: Long-Term Analysis of the IFM 99-02 and 99-04 Trials
- (2009) Jean-Luc Harousseau et al. JOURNAL OF CLINICAL ONCOLOGY
- Consolidation Therapy With Low-Dose Thalidomide and Prednisolone Prolongs the Survival of Multiple Myeloma Patients Undergoing a Single Autologous Stem-Cell Transplantation Procedure
- (2009) Andrew Spencer et al. JOURNAL OF CLINICAL ONCOLOGY
- Patterns of Improved Survival in Patients With Multiple Myeloma in the Twenty-First Century: A Population-Based Study
- (2009) Ingemar Turesson et al. JOURNAL OF CLINICAL ONCOLOGY
- Eliminating the complete response penalty from myeloma response criteria
- (2008) S. V. Rajkumar et al. BLOOD
- Eliminating the complete response penalty from myeloma response assessment
- (2008) S. Lonial et al. BLOOD
- Thalidomide-dexamethasone compared with melphalan-prednisolone in elderly patients with multiple myeloma
- (2008) H. Ludwig et al. BLOOD
- Multiparameter flow cytometric remission is the most relevant prognostic factor for multiple myeloma patients who undergo autologous stem cell transplantation
- (2008) B. Paiva et al. BLOOD
- The relationship between quality of response and clinical benefit for patients treated on the bortezomib arm of the international, randomized, phase 3 APEX trial in relapsed multiple myeloma
- (2008) Ruben Niesvizky et al. BRITISH JOURNAL OF HAEMATOLOGY
- Evaluation of minimal residual disease in multiple myeloma patients by fluorescent-polymerase chain reaction: the prognostic impact of achieving molecular response
- (2008) Pilar Martínez-Sánchez et al. BRITISH JOURNAL OF HAEMATOLOGY
- Influence of Pre- and Post-Transplantation Responses on Outcome of Patients With Multiple Myeloma: Sequential Improvement of Response and Achievement of Complete Response Are Associated With Longer Survival
- (2008) Juan José Lahuerta et al. JOURNAL OF CLINICAL ONCOLOGY
- Bortezomib plus Melphalan and Prednisone for Initial Treatment of Multiple Myeloma
- (2008) Jesús F. San Miguel et al. NEW ENGLAND JOURNAL OF MEDICINE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now